CSIMarket
 
Achilles Therapeutics Plc  (ACHL)
Other Ticker:  
 
 
Price: $1.1000 $-0.01 -0.901%
Day's High: $1.14 Week Perf: -10.57 %
Day's Low: $ 1.05 30 Day Perf: 12.83 %
Volume (M): 353 52 Wk High: $ 1.76
Volume (M$): $ 388 52 Wk Avg: $0.95
Open: $1.11 52 Wk Low: $0.74



 Market Capitalization (Millions $) 43
 Shares Outstanding (Millions) 39
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -71
 Cash Flow (TTM) (Millions $) -93
 Capital Exp. (TTM) (Millions $) 8

Achilles Therapeutics Plc
Achilles Therapeutics Plc is a biopharmaceutical company that specializes in the development of personalized cancer immunotherapies. The company utilizes a unique approach called Tumor Microenvironment Targeting to identify and target specific cancer mutations that are unique to each patient. This approach allows Achilles Therapeutics to create personalized, cell-based immunotherapies that can potentially improve the treatment outcomes for patients with solid tumors. The company's therapies aim to stimulate the patient's immune system to recognize and destroy cancer cells. Achilles Therapeutics Plc is based in the United Kingdom and is listed on the London Stock Exchange under the ticker symbol ACHL.


   Company Address: 245 Hammersmith Road London 0
   Company Phone Number: (0)20 8154 4600   Stock Exchange / Ticker: NASDAQ ACHL
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Unlocking the Potential: Advanced Computational Tools Harness Neoantigen Prediction for Improved Personalized Cancer Therapies

Published Mon, Dec 18 2023 12:00 PM UTC


Achilles Therapeutics, a prominent biotech company focused on personalized cancer therapies, recently announced the publication of a comment in Nature Cancer, discussing the significant advancements made in the field of neoantigen immunogenicity prediction. The comment highlights the potential of newly developed computational tools and extensive datasets with low bias t...






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com